Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.

ABSTRACT:

Importance

Hepatocellular carcinoma (HCC) surveillance is underused in clinical practice, which may be owing to patient and clinician barriers.

Objective

To characterize HCC surveillance barriers and associations with clinical outcomes in a multicenter cohort of patients with cirrhosis.

Design, setting, and participants

This retrospective, multicenter cohort study included 5 medical centers in the United States. Patients with cirrhosis and newly diagnosed HCC treated from 2014 to 2018 were included. Data were analyzed from June 2021 to February 2022.

Exposure

Surveillance completion in the 36-month period prior to HCC diagnosis.

Main outcomes and measures

Surveillance receipt was classified as semiannual, annual, or no surveillance. Multivariable logisti

SUBMITTER: Parikh ND 

PROVIDER: S-EPMC9308050 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature